BridgeBio Pharma Inc.
BBIO | NASDAQ
$75.60
+$0.65 (+0.87%)
Nov 2, 2026, 12:54 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.53B | 677.91M | 879.89M | 570.12M | 642.95M | 749.4M | 540.6M | 681.1M | 266.32M | 547.37M | 475.35M | 375.94M | 505.21M | 302.44M | 432.87M | 376.69M | 483.24M | 470.1M | 371.55M | 393.77M | 180.35M | 378.6M | 471.18M |
Short-Term Investments | 5.49M | 42.25M | 60.3M | 17.36M | 2.99M | 7.94M | n/a | n/a | n/a | 39.81M | 44.47M | 58.95M | 38.05M | 81.36M | 83.93M | 95.23M | 108.74M | 245.61M | 299.68M | 442.89M | 419.26M | 459.24M | 447.94M |
Long-Term Investments | 47.78M | 55.1M | 63.11M | 81.44M | 92.17M | 109.7M | 128.19M | 143.75M | 160.44M | 119.15M | 3.94M | 3.74M | 500K | 800K | 2.24M | 2.87M | 11.61M | 2.41M | n/a | 2.42M | 17.71M | 82.11M | 82.2M |
Other Long-Term Assets | 22.69M | 20.12M | -63.11M | -81.44M | 25.52M | 16.41M | 16.61M | 18.2M | 20.29M | 16.76M | 16.78M | 22.63M | 18.18M | 19.6M | 18.53M | 17.36M | 29.87M | 31.32M | 35.33M | 30.61M | 33.05M | 47.27M | 30.18M |
Receivables | 375.09M | 254.48M | 205.23M | 139.44M | 116.52M | 76.87M | 115.27M | 4.72M | 478K | 660K | 235.49M | 1.75M | 5.17M | 8.61M | 10.76M | 17.08M | 24.58M | 22.82M | 10.98M | 19.75M | 8.17M | 45.54M | 462K |
Inventory | 59.72M | 52.84M | 32.98M | 26.75M | 24.53M | 18.28M | 3.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | 5.03M | 59.79M | 3.23M | 3.83M | 148.91M | 28.4M | 131K | 27.65M | 16.65M | 19.93M | 25.14M | 37.93M | 140K | 140K | 177K | 177K | n/a | 26.49M | n/a |
Total Current Assets | 2.04B | 1.09B | 1.18B | 753.68M | 839.38M | 912.28M | 695.17M | 720.69M | 444.58M | 616.24M | 783.42M | 477.59M | 587.67M | 432.88M | 552.7M | 548.85M | 642.22M | 771.28M | 716.23M | 888.86M | 639.71M | 909.87M | 945.11M |
Property-Plant & Equipment | 20.79M | 22.31M | 22.17M | 13.52M | 12.38M | 12.29M | 13.86M | 12.78M | 15.14M | 17.11M | 19.47M | 19.84M | 21.75M | 22.86M | 24.1M | 25.25M | 27.34M | 29.72M | 31.12M | 45.97M | 44.85M | 42.24M | 35.81M |
Goodwill & Intangibles | 25.92M | 26.64M | 27.36M | 28.08M | 28.8M | 29.51M | 27.8M | 23.93M | 24.53M | 25.12M | 25.72M | 26.32M | 26.92M | 27.52M | 28.11M | 28.71M | 29.31M | 29.91M | 30.48M | 44.93M | 46.2M | n/a | n/a |
Total Long-Term Assets | 117.18M | 124.16M | 49.53M | 41.59M | 158.87M | 167.91M | 186.47M | 198.65M | 220.4M | 178.14M | 65.91M | 68.79M | 67.34M | 70.78M | 72.98M | 74.18M | 86.52M | 90.95M | 96.92M | 123.93M | 141.81M | 171.62M | 148.19M |
Total Assets | 2.16B | 1.22B | 1.37B | 936.03M | 998.25M | 1.08B | 881.64M | 919.34M | 664.98M | 794.38M | 849.33M | 546.38M | 655.01M | 503.66M | 625.68M | 623.04M | 728.74M | 862.23M | 813.15M | 1.01B | 781.52M | 1.08B | 1.09B |
Account Payables | 88.26M | 27.2M | 29.06M | 36.23M | 18.7M | 26.13M | 27.53M | 9.62M | 13.36M | 18.13M | 4.73M | 10.66M | 4.47M | 3.87M | 4.08M | 11.56M | 10.16M | 8.79M | 10.11M | 11.88M | 12.04M | 22.33M | 10.34M |
Deferred Revenue | 4.74M | 5.55M | 17.89M | 20.27M | 9.09M | 10.54M | n/a | n/a | 11.77M | 15.1M | 13.96M | 6.1M | n/a | n/a | 6.68M | 8.16M | 7.52M | 7.19M | n/a | n/a | n/a | 1.6M | n/a |
Short-Term Debt | 548.43M | 547.96M | 573.41M | 17.41M | n/a | 9.59M | n/a | n/a | n/a | 4.62M | n/a | n/a | n/a | n/a | 3.67M | n/a | n/a | n/a | n/a | n/a | n/a | 4.8M | 7.45M |
Other Current Liabilities | 212.11M | 192.19M | 196.01M | 214.06M | 64.76M | 85.52M | 16.12M | 16.2M | 43.54M | 67.46M | 85.85M | 65.6M | 12.59M | 16.84M | 63.3M | 31.26M | 72.63M | 88.26M | 1.5M | 37.04M | 3.5M | 81.32M | 52.39M |
Total Current Liabilities | 977.24M | 890.65M | 816.37M | 287.97M | 216.6M | 175.85M | 152.11M | 154.4M | 139.22M | 134.36M | 141.48M | 143.84M | 106.07M | 110.12M | 96.6M | 121.43M | 119.19M | 141.16M | 103.46M | 135.07M | 95.82M | 131.91M | 94.73M |
Long-Term Debt | 1.93B | 1.93B | 2.8B | 2.71B | 1.85B | 2.66B | 1.85B | 1.72B | 1.72B | 1.72B | 1.72B | 1.73B | 1.72B | 1.72B | 1.71B | 1.71B | 1.7B | 1.69B | 1.71B | 1.7B | 1.38B | 1.37B | 1.36B |
Other Long-Term Liabilities | 885.46M | 879.61M | 229K | 244K | 836.81M | 545K | 515.16M | 496.47M | 377K | 485K | 595K | 9.36M | 11.79M | 13.33M | 17.5M | 26.64M | 28.23M | 28.63M | 26.83M | 22.07M | 26.25M | 11.85M | 11.61M |
Total Long-Term Liabilities | 2.84B | 2.83B | 2.82B | 2.72B | 2.7B | 2.68B | 2.37B | 2.22B | 1.74B | 1.74B | 1.74B | 1.75B | 1.74B | 1.74B | 1.74B | 1.75B | 1.74B | 1.74B | 1.75B | 1.74B | 1.42B | 1.41B | 1.39B |
Total Liabilities | 3.82B | 3.72B | 3.64B | 3.01B | 2.92B | 2.86B | 2.52B | 2.38B | 1.88B | 1.88B | 1.89B | 1.89B | 1.85B | 1.85B | 1.84B | 1.87B | 1.86B | 1.88B | 1.85B | 1.88B | 1.52B | 1.54B | 1.48B |
Total Debt | 2.49B | 2.49B | 3.38B | 2.73B | 1.86B | 2.68B | 1.86B | 1.73B | 1.73B | 1.73B | 1.73B | 1.74B | 1.74B | 1.73B | 1.73B | 1.72B | 1.72B | 1.71B | 1.73B | 1.73B | 1.4B | 1.4B | 1.38B |
Book Value | -1.65B | -2.51B | -2.27B | -2.08B | -1.92B | -1.78B | -1.64B | -1.46B | -1.22B | -1.08B | -1.04B | -1.34B | -1.19B | -1.35B | -1.21B | -1.24B | -1.13B | -1.02B | -1.04B | -865.58M | -735.87M | -455.63M | -388.09M |
Book Value Per Share | -8.43 | -12.80 | -11.65 | -10.53 | -10.09 | -9.33 | -8.62 | -7.69 | -6.46 | -5.77 | -5.80 | -7.70 | -7.31 | -8.41 | -7.95 | -8.34 | -7.64 | -6.92 | -7.13 | -5.96 | -5.02 | -3.10 | -2.80 |
Common Stock | 207K | 206K | 204K | 202K | 200K | 198K | 197K | 196K | 195K | 194K | 193K | 181K | 180K | 168K | 167K | 157K | 156K | 154K | 154K | 154K | 153K | 153K | 152K |
Retained Earnings | -4.19B | -4.14B | -3.99B | -3.82B | -3.63B | -3.45B | -3.26B | -3.1B | -2.83B | -2.67B | -2.6B | -2.56B | -2.39B | -2.22B | -2.06B | -1.92B | -1.78B | -1.64B | -1.63B | -1.44B | -1.29B | -1.13B | -1.04B |
Comprehensive Income | -95K | -7K | -8K | 12K | 2K | 1K | n/a | 8K | 5K | -4K | 2K | 31K | 34K | 63K | -12K | -328K | -348K | -427K | -383K | -132K | 19K | 36K | -57K |
Shareholders Equity | -1.66B | -2.52B | -2.27B | -2.08B | -1.93B | -1.79B | -1.65B | -1.47B | -1.23B | -1.09B | -1.05B | -1.35B | -1.21B | -1.36B | -1.23B | -1.25B | -1.14B | -1.03B | -1.04B | -870.41M | -743.4M | -464.29M | -395.29M |
Total Investments | 53.28M | 97.34M | 123.4M | 98.81M | 95.16M | 117.64M | 128.19M | 143.75M | 160.44M | 158.96M | 48.41M | 62.69M | 38.55M | 82.16M | 86.16M | 98.1M | 120.35M | 248.02M | 299.68M | 445.31M | 436.97M | 541.36M | 530.14M |
Add to Watchlist
Select watchlists to add or remove BBIO